Dr David Brindley

Independent Non Executive Director

Dr David Brindley is an independent Non-Executive Director of Arkivum limited, bringing significant experience in GxP regulated life science applications. David leads the Healthcare Translation Group at the University of Oxford and is COO of a US vaccine company. Previously, David conducted research at the University of Oxford, University College London (UCL), Stanford University and Harvard University. Under David’s leadership a number of therapeutics and medical devices have entered clinical trials and achieved marketing authorization in the EU and US.

Our Advisory Board and Investors

Our Advisory Board consists of global industry executives with proven success in their respective fields. The Advisory Board supports us in evaluating growth opportunities and providing knowledgeable insights and advice to help Arkivum continue to grow.